The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 07, 1995

Filed:

Dec. 22, 1993
Applicant:
Inventors:

Waclaw J Rzeszotarski, Millersville, MD (US);

Suzanne R Ellenberger, Reisterstown, MD (US);

Maria E Guzewska, Pasadena, MD (US);

John W Ferkany, Baltimore, MD (US);

Gregory S Hamilton, Catonsville, MD (US);

Raymond J Patch, Baltimore, MD (US);

Edward W Karbon, Jr, Ellicott City, MD (US);

Assignee:

Guilford Pharmaceuticals Inc., Baltimore, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07F / ; A61K / ;
U.S. Cl.
CPC ...
514114 ; 558190 ; 558193 ; 560 20 ; 560 22 ; 560 23 ; 560 38 ; 560 40 ; 562 11 ;
Abstract

The present invention pertains to antagonists of excitatory amino acid neurotransmitter receptor antagonists, their method of preparation as well as compositions containing them which have the general formula: ##STR1## wherein n and m independently are 0, 1, 2, or 3; R.sub.1 is selected from the group consisting of hydrogen and R.sub.2 ; R.sub.2 is selected from the group consisting of hydrogen, halogen, halomethyl, nitro, amino, alkoxy, hydroxyl, hydroxymethyl, C.sub.1 to C.sub.6 lower alkyl, C.sub.7 to C.sub.12 higher alkyl, aryl and aralkyl, wherein if R.sub.2 is hydrogen, R.sub.1 is not hydrogen; R.sub.3 is selected from the group consisting of hydrogen and C.sub.1 to C.sub.6 lower alkyl; the stereoisomers thereof in their resolved or racemic form, and pharmaceutically acceptable salts thereof.


Find Patent Forward Citations

Loading…